title: Reconstructive options in the treatment of osteoradionecrosis of the craniomaxillofacial skeleton.
abstract: Osteoradionecrosis (ORN) of the craniomaxillofacial skeleton is a serious and debilitating complication that can occur following radiation therapy in the head and neck. Patients require effective treatment, which eradicates diseased tissue and restores function with minimal additional morbidity in a single stage, a requirement fulfilled in many cases by free tissue transfer. In a 6-year period from 1994 to 1999, 21 patients with ORN were treated by wide resection and free-flap reconstruction. The median interval between radiation therapy and ORN was 4 years (range: 1-33 years). The median radiation dose was 6000cGy. The affected areas were the mandible (15 patients), the temporal bone (three patients), the maxilla (one patient), the cervical vertebrae (one patient) and the frontal bone (one patient). Clinical symptoms included pain, ulceration, a persistent draining fistula, exposure of bone or hardware, and pathological fracture or non-union of bone. Six patients had had previous unsuccessful attempts at conservative surgical resection. Ten patients had preoperative hyperbaric oxygen (HBO) therapy. A number of different flaps were used for reconstruction in these patients. These included free fibula flaps (13 patients), iliac crest flaps (two patients), scapula flaps (three patients) and rectus abdominis flaps (three patients). All patients achieved relief from their presenting symptoms and primary bone or wound healing. One flap (4.8%) was lost. This was successfully reconstructed in a subsequent procedure. There were three flap re-explorations, two for arterial thrombosis and one for venous thrombosis. Conservative measures, such as limited debridement and HBO therapy, may be effective in preventing the progression of ORN. However, they fail to eradicate established ORN, which requires radical surgical resection followed by functional reconstruction with well-vascularised tissue.
authors.affiliation: Wharton Head and Neck Center, Princess Margaret Hospital, University of Toronto, Ontario, Toronto, Canada.
authors.forename: E
authors.initials: E
authors.lastname: Ang
authors.forename: C
authors.initials: C
authors.lastname: Black
authors.forename: J
authors.initials: J
authors.lastname: Irish
authors.forename: D H
authors.initials: DH
authors.lastname: Brown
authors.forename: P
authors.initials: P
authors.lastname: Gullane
authors.forename: B
authors.initials: B
authors.lastname: O'Sullivan
authors.forename: P C
authors.initials: PC
authors.lastname: Neligan
mesh_terms: D000368:Aged; D005147:Facial Bones / Q000528:radiation effects; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D006931:Hyperbaric Oxygenation; D008297:Male; D008334:Mandible / Q000528:radiation effects; D008437:Maxilla / Q000528:radiation effects; D008875:Middle Aged; D010025:Osteoradionecrosis / Q000628:therapy*; D012886:Skull / Q000528:radiation effects; D013524:Surgical Flaps